PMC:7126544 / 42735-43207 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T91","span":{"begin":113,"end":130},"obj":"Body_part"},{"id":"T92","span":{"begin":163,"end":180},"obj":"Body_part"},{"id":"T93","span":{"begin":212,"end":229},"obj":"Body_part"}],"attributes":[{"id":"A91","pred":"fma_id","subj":"T91","obj":"http://purl.org/sig/ont/fma/fma265130"},{"id":"A92","pred":"fma_id","subj":"T92","obj":"http://purl.org/sig/ont/fma/fma265130"},{"id":"A93","pred":"fma_id","subj":"T93","obj":"http://purl.org/sig/ont/fma/fma265130"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T51","span":{"begin":113,"end":130},"obj":"Body_part"},{"id":"T52","span":{"begin":163,"end":180},"obj":"Body_part"},{"id":"T53","span":{"begin":212,"end":229},"obj":"Body_part"}],"attributes":[{"id":"A51","pred":"uberon_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"},{"id":"A52","pred":"uberon_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"},{"id":"A53","pred":"uberon_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T351","span":{"begin":113,"end":141},"obj":"Disease"},{"id":"T352","span":{"begin":163,"end":191},"obj":"Disease"},{"id":"T353","span":{"begin":212,"end":240},"obj":"Disease"},{"id":"T354","span":{"begin":256,"end":265},"obj":"Disease"},{"id":"T355","span":{"begin":266,"end":274},"obj":"Disease"},{"id":"T356","span":{"begin":266,"end":270},"obj":"Disease"},{"id":"T357","span":{"begin":280,"end":313},"obj":"Disease"},{"id":"T358","span":{"begin":348,"end":381},"obj":"Disease"},{"id":"T359","span":{"begin":402,"end":410},"obj":"Disease"},{"id":"T360","span":{"begin":402,"end":406},"obj":"Disease"},{"id":"T361","span":{"begin":418,"end":451},"obj":"Disease"}],"attributes":[{"id":"A351","pred":"mondo_id","subj":"T351","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A352","pred":"mondo_id","subj":"T352","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A353","pred":"mondo_id","subj":"T353","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A354","pred":"mondo_id","subj":"T354","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A355","pred":"mondo_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A356","pred":"mondo_id","subj":"T356","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A357","pred":"mondo_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A358","pred":"mondo_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A359","pred":"mondo_id","subj":"T359","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A360","pred":"mondo_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A361","pred":"mondo_id","subj":"T361","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T343","span":{"begin":45,"end":50},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T344","span":{"begin":71,"end":76},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T345","span":{"begin":315,"end":317},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T346","span":{"begin":383,"end":385},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T81","span":{"begin":102,"end":107},"obj":"Chemical"},{"id":"T82","span":{"begin":152,"end":157},"obj":"Chemical"},{"id":"T83","span":{"begin":202,"end":206},"obj":"Chemical"},{"id":"T84","span":{"begin":251,"end":255},"obj":"Chemical"},{"id":"T85","span":{"begin":275,"end":279},"obj":"Chemical"},{"id":"T86","span":{"begin":343,"end":347},"obj":"Chemical"},{"id":"T87","span":{"begin":413,"end":417},"obj":"Chemical"}],"attributes":[{"id":"A81","pred":"chebi_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"},{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"},{"id":"A83","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A84","pred":"chebi_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A85","pred":"chebi_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A86","pred":"chebi_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A87","pred":"chebi_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T119","span":{"begin":113,"end":141},"obj":"Phenotype"},{"id":"T120","span":{"begin":163,"end":191},"obj":"Phenotype"},{"id":"T121","span":{"begin":212,"end":240},"obj":"Phenotype"},{"id":"T122","span":{"begin":256,"end":265},"obj":"Phenotype"}],"attributes":[{"id":"A119","pred":"hp_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/HP_0011947"},{"id":"A120","pred":"hp_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/HP_0011947"},{"id":"A121","pred":"hp_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/HP_0011947"},{"id":"A122","pred":"hp_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T356","span":{"begin":0,"end":70},"obj":"Sentence"},{"id":"T357","span":{"begin":71,"end":91},"obj":"Sentence"},{"id":"T358","span":{"begin":92,"end":141},"obj":"Sentence"},{"id":"T359","span":{"begin":142,"end":191},"obj":"Sentence"},{"id":"T360","span":{"begin":192,"end":240},"obj":"Sentence"},{"id":"T361","span":{"begin":241,"end":265},"obj":"Sentence"},{"id":"T362","span":{"begin":266,"end":333},"obj":"Sentence"},{"id":"T363","span":{"begin":334,"end":401},"obj":"Sentence"},{"id":"T364","span":{"begin":402,"end":472},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1131","span":{"begin":92,"end":101},"obj":"Species"},{"id":"1132","span":{"begin":142,"end":151},"obj":"Species"},{"id":"1133","span":{"begin":192,"end":201},"obj":"Species"},{"id":"1134","span":{"begin":266,"end":274},"obj":"Species"},{"id":"1135","span":{"begin":334,"end":342},"obj":"Species"},{"id":"1136","span":{"begin":402,"end":412},"obj":"Species"},{"id":"1137","span":{"begin":431,"end":442},"obj":"Species"},{"id":"1138","span":{"begin":113,"end":141},"obj":"Disease"},{"id":"1139","span":{"begin":163,"end":191},"obj":"Disease"},{"id":"1140","span":{"begin":212,"end":265},"obj":"Disease"},{"id":"1141","span":{"begin":280,"end":313},"obj":"Disease"},{"id":"1142","span":{"begin":319,"end":328},"obj":"Disease"},{"id":"1143","span":{"begin":348,"end":381},"obj":"Disease"},{"id":"1144","span":{"begin":387,"end":396},"obj":"Disease"},{"id":"1145","span":{"begin":458,"end":467},"obj":"Disease"},{"id":"1148","span":{"begin":45,"end":50},"obj":"Species"},{"id":"1149","span":{"begin":51,"end":64},"obj":"Species"}],"attributes":[{"id":"A1131","pred":"tao:has_database_id","subj":"1131","obj":"Tax:11137"},{"id":"A1132","pred":"tao:has_database_id","subj":"1132","obj":"Tax:277944"},{"id":"A1133","pred":"tao:has_database_id","subj":"1133","obj":"Tax:31631"},{"id":"A1134","pred":"tao:has_database_id","subj":"1134","obj":"Tax:694009"},{"id":"A1135","pred":"tao:has_database_id","subj":"1135","obj":"Tax:1335626"},{"id":"A1136","pred":"tao:has_database_id","subj":"1136","obj":"Tax:2697049"},{"id":"A1137","pred":"tao:has_database_id","subj":"1137","obj":"Tax:12814"},{"id":"A1138","pred":"tao:has_database_id","subj":"1138","obj":"MESH:D012141"},{"id":"A1139","pred":"tao:has_database_id","subj":"1139","obj":"MESH:D012141"},{"id":"A1140","pred":"tao:has_database_id","subj":"1140","obj":"MESH:D012141"},{"id":"A1141","pred":"tao:has_database_id","subj":"1141","obj":"MESH:D045169"},{"id":"A1142","pred":"tao:has_database_id","subj":"1142","obj":"MESH:D003643"},{"id":"A1143","pred":"tao:has_database_id","subj":"1143","obj":"MESH:D045169"},{"id":"A1144","pred":"tao:has_database_id","subj":"1144","obj":"MESH:D003643"},{"id":"A1145","pred":"tao:has_database_id","subj":"1145","obj":"MESH:D003643"},{"id":"A1148","pred":"tao:has_database_id","subj":"1148","obj":"Tax:9606"},{"id":"A1149","pred":"tao:has_database_id","subj":"1149","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}

    2_test

    {"project":"2_test","denotations":[{"id":"32143990-31967327-55637412","span":{"begin":66,"end":68},"obj":"31967327"}],"text":"Table 2 Partial list of important pathogenic human coronaviruses [87].\nVirus Genus Symptoms\nHCoV-229E alpha mild respiratory tract infections\nHCoV-NL63 alpha mild respiratory tract infections\nHCoV-OC43 beta mild respiratory tract infections\nHCoV-HKU1 beta pneumonia\nSARS-CoV beta severe acute respiratory syndrome, 11% mortality rate\nMERS-CoV beta severe acute respiratory syndrome, 34% mortality rate\nSARS-CoV-2 beta severe acute respiratory syndrome, 2.6% mortality rate"}